NOTE 8 - EQUITY TRANSACTIONS | NOTE 6 – EQUITY TRANSACTIONS Employee stock compensation expense for the three-month period ending March 31, 2023 and 2022 amounted to $376,573 and $199,843 respectively. Class A Common Shares Issued in exchange for services, trade payables and related party debt On March 31, 2022, the Company issued 884,229 class A common shares pursuant to the conversion of $1,006,726 of accrued interest. Warrant Exercises On January 13, 2022, the Company issued 117,250 shares of Class A Common Stock based upon a cash pay warrant exercise. The share price at issuance was $1.50. On March 30, 2022, the Company issued 47,500 shares of Class A Common Stock based upon a cash pay warrant exercise. The share price at issuance was $1.50. On March 31, 2022, the Company issued 22,500 shares of Class A Common Stock based upon a cash pay warrant exercise. The share price at issuance was $1.50. New Warrant Issuances On January 26, 2022, the Company issued Common Stock Purchase Warrant “A-10” for rare earth capture advisory. The warrant provides the option to purchase 10,000 Class A Common Shares at a price of $2.05. The warrants expire on January 26, 2024. On February 2, 2022, the Company issued Common Stock Purchase Warrant “C-37” in conjunction with the issuance of $600,000 convertible note. The warrant provides the option to purchase 60,000 Class A Common Shares at a price of $1.50. The warrants expire on February 2, 2023. On February 7, 2022, the Company issued Common Stock Purchase Warrant “A-11” for rare earth processing advisory. The warrant provides the option to purchase 50,000 Class A Common Shares at a price of $4.25. The warrants expire on February 7, 2026. The company uses the Black Scholes option pricing model to value its warrants and options. The significant inputs are as follows: March 31, 2023 March 31, 2022 Expected Dividend Yield 0 % 0 % Expected volatility 87.97 % 123-617 % Risk-free rate 2.37 % 1.40-1.62 % Expected life of warrants .22-8.75 years 1.635-5.588 years Company Warrants: Weighted Weighted Average Average Aggregate Number of Exercise Contractual Intrinsic Warrants Price Life in Years Value Exercisable (Vested) – December 31, 2021 8,401,221 $ 1.135 2.152 $ 7,453,214 Granted 60,000 $ 3.883 4.521 $ 18,000 Forfeited or Expired - $ - - $ - Exercised 1,681,022 $ 1.215 3.094 $ 5,321,781 Outstanding - March 31, 2022 6,780,199 $ 1.139 1.635 $ 18,277,625 Exercisable (Vested) - March 31, 2022 6,780,199 $ 1.139 1.635 $ 18,277,625 Exercisable (Vested) – December 31, 2022 9,724,369 $ 2.75 1.69 $ 6,515,327 Granted - $ - - $ 121,018 Forfeited or Expired - $ - - $ - Exercised - $ - - $ - Outstanding - March 31, 2022 9,724,369 $ 2.75 1.45 $ 9,724,369 Exercisable (Vested) - March 31, 2022 9,724,369 $ 2.75 1.45 $ 9,724,369 Company Options: Weighted Weighted Average Average Aggregate Number of Exercise Contractual Intrinsic Options Price Life in Years Value Outstanding – December 31, 2021 2,159,269 $ 1.606 5.660 $ 1,919,129 Exercisable (Vested) – December 31, 2021 888,659 $ 1.581 5.047 $ 749,470 Granted 75,000 $ 2.560 6.847 $ 105,000 Forfeited or Expired 50,000 $ 1.050 - $ - Exercised - $ - - $ - Outstanding - March 31, 2022 2,184,269 $ 1.651 5.588 $ 5,010,909 Exercisable (Vested) - March 31, 2022 938,659 $ 1.739 5.260 $ 2,149,710 Outstanding – December 31, 2022 5,834,268 $ 1.665 5.39 $ 3,186,870 Exercisable (Vested) – December 31, 2022 3,159,268 $ 1.517 4.91 $ 3,141,183 Granted - $ - - $ - Forfeited or Expired - $ - - $ - Exercised - $ - - $ - Outstanding - March 31, 2023 5,834,268 $ 1.665 5.14 $ 5,484,212 Exercisable (Vested) - March 31, 2023 3,159,268 $ 1.517 4.67 $ 2,906,527 |